EDGAR Filing Documents for 0001144204-17-062743

Form 8-K - Current report:

SEC Accession No. 0001144204-17-062743

Filing Date

2017-12-07

Accepted

2017-12-07 13:03:55

Documents

Period of Report

2017-12-06

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	tv480957_8k.htm	8-K	25435
2	EXHIBIT 2.1	tv480957_ex2-1.htm	EX-2.1	11308
3	EXHIBIT 99.1	tv480957_ex99-1.htm	EX-99.1	13744
4	EXHIBIT 99.2	tv480957_ex99-2.htm	EX-99.2	30785
5	GRAPHIC	image_001.jpg	GRAPHIC	7820
6	GRAPHIC	image_002.jpg	GRAPHIC	6413
	Complete submission text file	0001144204-17-062743.txt		102522

Mailing Address 1450 INFINITE DRIVE LOUISVILLE CO 80027

Business Address 1450 INFINITE DRIVE LOUISVILLE CO 80027 650-847-1919

AntriaBio, Inc. (Filer) CIK: 0001509261 (see all company filings)